HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day

HubSpot 、 Kraft Heinz 、 CNBS 、 Canopy Growth 、奥罗拉(Aurora) Cannabis 和 GW Pharmaceuticals 被强调为当天的 Zacks Bull 和 Bear

2019-08-14 21:38:01 Zacks


  For Immediate Release Chicago, IL – August 14, 2019 – Zacks Equity Research Shares of HubSpot HUBS as the Bull of the Day, Kraft Heinz KHC as the Bear of the Day. In addition, Zacks Equity Research provides analysis on CNBS, Canopy Growth CGC, Aurora Cannabis ACB and GW Pharmaceuticals GWPH.Here is a synopsis of all five stocks: Bull of the Day: HubSpot hit the spot for investors in its earnings report last week with a big beat on sales and EPS estimates, sending share surging 13.5%. This positive earnings story has analysts revising their models upward and propelling HUBS into a Zacks Rank #1 (Strong Buy). The Business HubSpot provides companies with software as a service (SaaS). It delivers cloud-based business services with segments including Marketing Hub, Sales Hub, Service Hub, and a free CRM system. This is a company with a growing international presence, generating 32% of sales coming from operations abroad. HubSpot’s started with its Marketing Hub and has built its system out from their since its IPO in 2014 with free CRM and a preliminary Sales Hub. In 2017 the firm added its Service Hub for customer service support. HubSpot’s goal is create a seamless customer experience that allows businesses to “grow better”. Their target customers are small to medium sized businesses that have large growth potential. HubSpot has nearly 65,000 customers spread across more than 100 countries, representing 35% growth year-over-year. Multiplatform customers grew 80% since Q2 last year and multiplatform users now make up over 38% of HubSpot’s total customer base. This is a great sign for a young SaaS company, illustrating customer confidence in HubSpot and its platforms ability to improve business operations. According to HubSpot’s CEO, Brian Halligan, “customers on average integrate more than five different third-party applications with HubSpot.” The ability to integrate platforms could make or break a firm’s decision of whether to use HubSpot’s platforms. This firm is investing more in its developer experience to smooth out any developer speedbumps. The firm focusses on small to medium size companies as their niche market, though their tiered system allows them to broaden that product offering. The segmented tiered system expands HubSpot’s total addressable market (TAM). HubSpot is expanding its freemium offering to entice more firms to try out their product. This might cause some customers to initially downgrade but the long-run benefits of the broadened exposure will far outweigh this short-term drop. Having a strong freemium platform is a crucial pipeline for a subscription based service like this. Top competitors in the SaaS space include Salesforce CRM, Microsoft Azure MSFT, and Google Cloud GOOGL. Financials and Performance Since HubSpot went public 5 years ago it has been able to illustrate consistent year-over-year and quarter-over-quarter topline growth with a compounded annually growth rate (CAGR) of 42%. HUBS international sales growth outpaces domestic at 62% CAGR. This firm has been able to achieve economies of scale over the last five years, continuously expanding margins. HubSpot posted an 8.3% operating margin this past quarter with a long term target of 20% - 25% (2% - 3% improvement per year). Below you can see HubSpot’s gross and operating margins over the last 5 years. HubSpot has rallied hard thus far in 2019 returning shareholders 51%, far outperforming the broader market and the software industry. HubSpot’s consistent topline growth quarter-over-quarter allows investors to be comfortable with an excessively high multiple. This is not of concern when evaluating an equity with so much growth potential. Analyst are estimating 30% topline growth and a 57% EPS expansion just this year. Take Away HubSpot is operating in the competitive SaaS space, but I believe that its niche positioning in the market gives them a competitive edge. Start-ups and growing businesses still need the same cloud-based business infrastructure. I expect this company to continue to proliferate growth domestic as well as internationally as businesses becomes more competitive and the demand for SaaS escalates. Bear of the Day: Kraft Heinz continues to disappoint investors with continuous brand write-downs, pessimistic management guidance and a 36% dividend cut. KHC has lost almost 40% of its value since the start of 2019 and over 56% of it market cap flushed down the toilet in the last 52-weeks. Sell-side analysts continue to drop EPS estimates with management’s sizable downward revisions propelling KHC into a Zacks Rank #5 (Strong Sell). Kraft Heinz is facing substantial systemic issues that management has not seemed to be able to alleviate in recent quarters. In fact it appears the problems are accelerating. The Brazilian private equity firm, 3G Capital, merged Kraft and Heinz with the help of investment guru Warren Buffet and his firm Berkshire Hathaway. This merger occurred in July of 2015 and was able to initially provide positive results with the new 3G managements cost cutting, margin expanding measures. The primary issue with this strategy is the quintessential private equity move. They go into a firm gut management and lean up operations to eventually sell off for a profit. Unfortunately it didn’t work for a company of this size with such solidified brand names. It appears that Kraft cut its cost too far leading to brand deterioration. The company has had to continuously write-down its brand over the last few years with the last 6 months exemplifying over $1.2 billion in impairment charges. Kraft Heinz net income fell a drastic 51.4% year-over-year in the first half of 2019 on sales that were down over 51% compared to the first half of 2018. Margins have continued to deteriorate, and I don’t see this trend changing anytime soon under current management. Take Away Private equity firms don’t know how to operate a growing brand-based business, they are too focused on short-term profitability. Consistent brand impairment charges are a sign that this company doesn’t expect to recoup market share anytime soon and that profitability may have an expiration date. The best thing that could happen to Kraft Heinz is a buyout from a more properly run CPG company with management that is willing to continue to grow its long-standing brands oppose to turning a short-term profit. Additional content: Cannabis Expert Tim Seymour’s Favorite Pot Stocks and ETF (Please use this Libsyn link: In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, founder & CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF, which is actively managed by Tim. We start with the investment case for cannabis--why investors should consider marijuana stocks and ETFs. Per Amplify, global legal cannabis sales have risen approximately 30% per year recently, with 2019 sales expected to grow 39% from 2018. Tim is an early stage cannabis investor and also serves as a board member for several private cannabis companies. What drew him to the cannabis industry? Recreational marijuana use is now legal in 11 states and Washington D.C. and medical marijuana use is legal in 33 states, but it remains illegal at the federal level. We discuss the current regulatory landscape, rising support for legalizing cannabis and recent legislative developments. CNBS invests in marijuana companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. Its top holdings include Canopy Growth , Aurora Cannabis, GW Pharmaceuticals MediPharm Labs, Organigram Holdings, Village Farms International, and Canaccord Genuity. Tim talks about some of his favorite cannabis stocks. There are four more pot ETFs available to investors now--the ETFMG Alternative Harvest ETF (MJ), the AdvisorShares Pure Cannabis ETF, The Cannabis ETF, and the Cambria Cannabis ETF. How is CNBS different from other pot ETFs? Are there any pot stocks investors should stay away from? CannTrust Holdings has lost more than 50% of its value since it disclosed a serious regulatory breach on July 8.  What else do investors need to know? Amplify has a number of ETFs focused on disruptive themes, like the Amplify Online Retail ETF. We talk about the role of thematic ETFs in investors’ portfolios. Please visit to learn more about CNBS and other Amplify ETFs. Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email Want key ETF info delivered straight to your inbox? Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >> Media Contact Zacks Investment Research 800-767-3771 ext. 9339 provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer.   Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.
这是一个很好的例子 有关即时发布 芝加哥, IL-2019年8月14日- Zacks 股票研究股份的 HubSpot HUBS 作为公牛的一天,卡夫亨氏 KHC 作为熊的一天。此外, Zacks 股权研究提供了 CNBS 、 Canopy Growth CGC 、奥罗拉(Aurora) Cannabis ACB 和 GW Pharmaceuticals GWPH 的分析。以下是所有五只股票的概要: 一天中的公牛: HubSpot 上周发布的收益报告显示,该公司销售额和每股收益均大幅飙升,股价飙升13.5%。这一积极的盈利故事让分析师们向上修正他们的模型,并推动 HUBS 成为 Zacks 排名第一(强劲购买)。 业务 HubSpot 为公司提供软件即服务( SaaS )。它提供基于云的业务服务,包括市场营销枢纽、销售枢纽、服务枢纽和免费 CRM 系统。这家公司的国际业务不断增长,32%的销售额来自海外业务。 HubSpot 从营销中心起步,自2014年首次公开发行( IPO )以来,该公司利用免费的 CRM 和初步的销售中心构建了自己的系统。2017年,公司为客户服务支持增加了服务中心。HubSpot 的目标是创造一种无缝的客户体验,使企业能够“更好地发展”。他们的目标客户是具有巨大增长潜力的中小型企业。 HubSpot 在100多个国家拥有近6.5万客户,同比增长35%。自去年第二季度以来,多平台客户增长了80%,多平台用户现在占 HubSpot 总客户群的38%以上。对于一家年轻的 SaaS 公司来说,这是一个很好的标志,表明了客户对 HubSpot 及其平台改善业务运营的信心。 HubSpot 首席执行官布赖恩•哈利根( Brian Halligan )表示:“客户平均将五种不同的第三方应用程序与 HubSpot 集成在一起。”整合平台的能力可能会让公司决定是否使用 HubSpot 的平台。该公司正加大对开发人员经验的投资,以消除开发人员的任何速度冲击。 该公司把重点放在中小型公司作为他们的利基市场,尽管他们的分层系统允许他们扩大产品提供。分段分层系统扩展了 HubSpot 的总可寻址市场( TAM )。 HubSpot 正在扩大其免费增值服务,以吸引更多公司试用他们的产品。这可能会导致一些客户最初下调评级,但扩大敞口的长期好处将远远超过这一短期下跌。拥有一个强大的免费增值平台是一个关键的管道为订阅服务这样。 SaaS 领域的主要竞争对手包括 Salesforce CRM 、 Microsoft Azure MSFT 和 Google Cloud GOOGL 。 财务及表现 自5年前 HubSpot 上市以来,该公司一直能够以42%的复合年增长率(复合年增长率)说明连续的同比和环比增长。HUBS 国际销售增长超过国内,复合年增长率为62%。 这家公司在过去五年中实现了规模经济,不断扩大利润率。HubSpot 上个季度的营业利润率为8.3%,长期目标为20%-25%(每年增长2%-3%)。下面是 HubSpot 过去5年的毛利润和营业利润率。 HubSpot 在2019年迄今强劲反弹,股东回报率为51%,远远超过整体市场和软件行业。 HubSpot 季度环比持续增长,让投资者对过高的倍数感到放心。在评估具有如此大增长潜力的股票时,这并不令人担心。分析师估计,仅今年,该公司的营收增长30%,每股盈利增长57%。 走出去吧 HubSpot 在竞争激烈的 SaaS 领域运营,但我相信它在市场中的定位给了它们竞争优势。初创企业和成长型企业仍需要相同的基于云的业务基础设施。我预计,随着企业变得更具竞争力,对 SaaS 的需求不断上升,该公司将继续在国内和国际范围内快速增长。 日的熊: 卡夫亨氏( Kraft Heinz )继续通过持续的品牌减记、悲观的管理指引和36%的股息削减,令投资者失望。自2019年初以来, KHC 的市值缩水了近40%,过去52周里,超过56%的市值冲下了厕所。卖方分析师继续下调 EPS 预期,管理层大幅下调业绩预期,推动 KHC 进入 Zacks 排名第五(强劲销售)。 卡夫亨氏正面临重大系统性问题,最近几个季度,管理层似乎无法缓解这些问题。事实上,问题似乎正在加速。 巴西私募股权公司3G 资本在投资大师沃伦·巴菲特和他的伯克希尔·哈撒韦公司的帮助下合并了卡夫和亨氏。这次合并发生在2015年7月,并能够初步提供积极的结果与新的3G 管理成本削减,利润扩大措施。 这一战略的主要问题是典型的私人股本行动。他们进入一个坚定的直觉管理和精简业务,最终出售利润。不幸的是,对于这样规模的公司来说,它并不适用于这样的固化品牌。 看来卡夫削减成本太多导致品牌恶化。过去几年,该公司不得不不断减记品牌,过去6个月的减值支出超过12亿美元。 卡夫亨氏2019年上半年净利润同比大幅下降51.4%,销售额较2018年上半年下降超过51%。利润持续恶化,我认为在当前的管理下,这种趋势不会很快改变。 走出去吧 私人股本公司不知道如何经营日益增长的基于品牌的业务,它们过于注重短期盈利能力。一致的品牌减值费用表明,该公司预计不会很快收回市场份额,盈利能力可能有一个到期日。 卡夫亨氏可能面临的最好情况是,从一家经营状况更好的 CPG 公司收购,这家公司的管理层愿意继续发展其长期品牌,反对转变短期利润。 补充内容: Cannabis 专家 Tim Seymour 最喜欢的 Pot 股票和 ETF (请使用此 Libsyn 链接: ) 在这期 ETF Spotlight 中,我与 Seymour 资产管理公司创始人兼首席信息官、 CNBC Fast Money 的联合主持人 TimSeymour 以及 Amplify ETF 创始人兼首席执行官 Christian Magoo 进行了谈话。 我们讨论大麻投资和 Amplify Seymour Cannabis ETF ,这是由 Tim 积极管理的。 我们从大麻的投资案例开始——为什么投资者应该考虑大麻股票和 ETF 。最近,全球合法大麻销售额每年增长约30%,2019年的销售额预计比2018年增长39%。 Tim 是大麻早期投资者,也是几家私人大麻公司的董事会成员。是什么把他吸引到大麻行业呢? 目前,在11个州和华盛顿特区,娱乐大麻的使用是合法的,在33个州,医用大麻的使用是合法的,但在联邦一级仍然是非法的。我们讨论了目前的监管格局、对大麻合法化的日益支持以及最近的立法发展。 CNBS 投资于大麻公司,这些公司从大麻和大麻生态系统中获得50%或更多的收入。其主要资产包括 Canopy Growth 、奥罗拉(Aurora) Cannabis 、 GW PharmaceuticalMedicalPharm Labs 、 Organigram Holdings 、 Village Farms International 和 Canaccord Genuity 。 蒂姆谈到了他最喜欢的大麻库存。 目前,投资者还有四只可投资的盆底 ETF : ETFMG 另类收获 ETF ( MJ )、 Advisors Shares Pure Cannabis ETF 、 Cannabis ETF 和 Cambria Cannabis ETF 。中国结算系统与其他基金 ETF 有何不同? 有没有股票股投资者应该远离?佳能信托控股( CannTrust Holdings )自7月8日披露严重违反监管规定以来,已损失逾50%的市值。投资者还需要知道什么呢? Amplify 有许多专注于颠覆性主题的 ETF ,比如 Amplify Online Retail ETF 。我们讨论主题 ETF 在投资者投资组合中的作用。 请访问 AmplifyETF 。了解更多关于 CNBS 和其他 Amplify ETF 的信息。 请务必留意下一版 ETF Spotlight !如果您有任何意见或问题,请发送电子邮件至 podcast @ 。 想要关键的 ETF 信息直接发送到您的收件箱? Zacks 的免费基金通讯每周都会向您简要介绍顶级新闻和分析以及表现最佳的 ETF 。免费获得>> 媒体联系人 Zacks 投资研究 800-767-3771 ext 。9339 support @ 扎克斯。com 提供投资资源,并告知您这些资源,您可以选择使用这些资源来进行自己的投资决策。Zacks 根据 Zacks “服务条款和条件”免责声明向您提供有关此资源的信息。 /免责声明。 过去的表现并不能保证将来的结果.任何投资固有的潜在损失。本材料仅供参考之用,本材料不构成投资、法律、会计或税务建议,也不构成购买、出售或持有证券的建议。对于任何投资是否适合某一特定投资者,没有提出建议或建议。不应假定在确定和描述的证券、公司、部门或市场上的任何投资是或将是盈利的。所有信息截至本协议签订之日均为最新信息,如有变更,恕不另行通知。所表达的任何观点或观点都不能反映公司整体的观点或观点。Zacks 投资研究公司不从事任何证券的投资银行业务、做市或资产管理活动。这些收益来自假设投资组合,包括 Zacks Rank =1的股票,这些股票每月重新平衡,交易成本为零。这些不是股票实际投资组合的回报。标准普尔500指数是一个非管理指数。有关本新闻稿中显示的性能号码的信息,请访问 。